Understanding Financial Toxicity in Management of Advanced Prostate Cancer from Qualitative Approach

Overview

About this study

The purpose of this study is to identify characteristics of financial toxicity unique to advanced prostate cancer, especially those areas not assessed through current objective measures, and describe how can these areas inform potential interventions to ameliorate financial toxicity.

This aim will be accomplished through qualitative focus group study of advanced prostate cancer patients who exhibit both extremes of financial toxicity. Findings will be presented in a joint display with quantitative survey data obtained in a prior study.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18 years and older, diagnosed with metastatic prostate cancer.

Exclusion Criteria: 

  • Have an additional non-prostate cancer diagnosis, have non-metastatic prostate cancer recurrence.

Eligibility last updated 6/7/22. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Stephen Boorjian, M.D.

Open for enrollment

Contact information:

Daniel Joyce M.D.

(612) 594-2345

Joyce.Daniel@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20538913

Mayo Clinic Footer